Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Response of meningeal stromal cells against virus infection

ABSTRACT: The role of meningeal stromal cells in meningeal antiviral immunity has been poorly studied. Here we investigated the response of meningeal stromal cells in combating LCMV viral infection.

ORGANISM(S): Mus musculus

PROVIDER: GSE263665 | GEO | 2026/03/13

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Response of meningeal mast cells against virus infection

Project description:The role of meningeal mast cells in meningeal antiviral immunity has been poorly studied. Here we investigated the important role of meningeal mast cells in combating LCMV viral infection.

2026-03-13 | GSE263668 | GEO

ST2 signaling orchestrates mast cell transcriptional activation during viral infection

Project description:The role of meningeal mast cells ST2 signaling in meningeal antiviral immunity has been poorly studied. Here we investigated the important role of meningeal mast cells ST2 signaling in combating LCMV viral infection.

2026-03-13 | GSE298700 | GEO

Post-natal meningeal macrophages protect against viral neuroinfection

Project description:Due to the vital importance of the Central Nervous System (CNS), its potential infection and inflammation have to be tightly controlled. The surface of the CNS is connected to the periphery by a rich and complex tissue, the meninges. They contain a vast network of macrophages subdivided in at least two subpopulations endowed with elusive functions: a neonatal, MHC-II negative macrophage population, and an post-natal population expressing MHC-II. Using in situ-histocytometry, flow cytometry, and single-cell RNA sequencing approaches, we showed that those populations have opposite dynamic behaviors in response to in vivo peripheral challenges such as LPS, SARS-CoV2 and lymphocytic choriomeningitis virus (LCMV), with an apparent contraction of the MHC-II+ population. Focusing on LCMV infection in experimental mouse models and using innovative pharmacological and genetic depletion strategies, we show that meningeal macrophages (MM) represent an early line of protection against this neuroinvasive pathogen. In their absence, specific areas in the meninges became highly infected, leading to fatal brain disease. While their intrinsic sensing of viral replication through the Mitochondrial antiviral-signaling protein (MAVS) was dispensable, sensing of IFNs through the STAT1 pathway played an important role in controlling viral spread. Unexpectedly, the post-natal MHC-II+ macrophage population had an important role in controlling neuroinfection, by shutting down biosynthesis pathways and efficiently blocking viral replication. This work helps understanding the spatial organization of the brain defense system and the cellular and molecular mechanisms involved in CNS protection.

2021-12-02 | GSE189887 | GEO

Characterization of the dural meninges against viral infection

Project description:The meninges serve as a protective barrier for the brain and are essential in combating pathogen attacks, such as viral infections, that could otherwise result in fatal outcomes. To delineate the immune response during viral infection, we performed sc-RNA sequencing after 6 days LCMV Armstrong infection when the immune response was highly active.

2026-03-13 | GSE263670 | GEO

Immunotherapy against amyloid beta is modulated by meningeal lymphatic function VI

Project description:A growing body of evidence points to passive immunotherapy as a promising therapeutic strategy against AD. Herein, we show that meningeal lymphatic vasculature becomes dysfunctional in AD transgenic mice and that manipulating meningeal lymphatic drainage affects the outcome of anti-Aβ immunotherapy.

2021-03-11 | GSE160220 | GEO

Immunotherapy against amyloid beta is modulated by meningeal lymphatic function V

2021-03-11 | GSE160219 | GEO

Immunotherapy against amyloid beta is modulated by meningeal lymphatic function III

2021-03-11 | GSE141915 | GEO

Immunotherapy against amyloid beta is modulated by meningeal lymphatic function IV

2021-03-11 | GSE160216 | GEO

Immunotherapy against amyloid beta is modulated by meningeal lymphatic function II

2021-03-11 | GSE141872 | GEO

Immunotherapy against amyloid beta is modulated by meningeal lymphatic function I

2021-03-11 | GSE141849 | GEO